Deliver Your News to the World

ChemImage Promotes Dr. Matthew P. Nelson to Threat Detection Line of Business Director


PITTSBURGH, PA  - ChemImage Corp. is pleased to announce that Dr. Matthew P. Nelson has been promoted to Director of the company’s Threat Detection Business.

In his new role, Dr. Nelson will be responsible for the strategic planning and budgeting; business development and sales support; and management of the day-to-day operations for the Threat Detection Line of Business.  He will also provide focused leadership during the development of all current and future line of business products including ChemImage’s real-time standoff explosive detection systems.

Dr. Nelson joined ChemImage in 1999 as a Senior Scientist.   During his 14 years at the company, he advanced to Chief Scientist where he lead the spectroscopy and imaging contract research and R&D study efforts, secured research funding from federal and state granting agencies and developed new Chemical Imaging and spectroscopy technologies for the chemical, material science and clinical markets.  He has authored/co-authored dozens of publications, 3 book chapters and has been an inventor/co-inventor on 48 issued patents.

“Dr. Nelson has shown his ability as a leader since his arrival at ChemImage,” said Jim McGlone, President at ChemImage. “We will rely heavily on his leadership as we set to launch new products in the coming year.”

Dr. Nelson received his Ph.D. in Analytical Chemistry from the University of South Carolina and serves as the Raman Imaging Task Force Chair for ASTM Subcommittee E13.10 on Molecular Spectroscopic Optical Imaging.  He is a long time resident of Harrison City, PA, where he attends Community Church (A United Methodist Congregation) and is an assistant coach for his son’s dek hockey team.

About ChemImage
ChemImage Corporation, a leader in hyperspectral imaging technology (i.e., molecular chemical imaging), provides instrumentation, software, contract services and expert consulting to government, industrial and academic organizations. The company’s proprietary, state-of-the-art hyperspectral imaging technology has many applications, including defense, security, pharmaceuticals, forensics and biomedical diagnostic research, which can reveal critical chemical and biological information from a variety of material systems.
ChemImage’s headquarters are located in Pittsburgh, PA, where it houses research and development laboratories, as well as engineering and manufacturing facilities. 


 Threat Detection

This news content may be integrated into any legitimate news gathering and publishing effort. Linking is permitted.

News Release Distribution and Press Release Distribution Services Provided by WebWire.